newdrugapprovals.org
FDA expands approval of Blincyto (blinatumomab) for treatment of a type of leukemia in patients who have a certain risk factor for relapse
FDA expands approval of Blincyto for treatment of a type of leukemia in patients who have a certain risk factor for relapse Blincyto (blinatumomab) The U.S. Food and Drug Administration granted acc…